Production (Stage)
Precigen, Inc.
PGEN
$1.33
$0.000.00%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -23.40% | -37.39% | -41.55% | -80.17% | -76.51% |
| Total Other Revenue | 182.35% | 266.67% | 8.70% | -72.53% | -89.57% |
| Total Revenue | -22.76% | -36.95% | -41.38% | -80.14% | -76.60% |
| Cost of Revenue | 10.43% | -7.29% | 68.34% | 29.49% | 23.18% |
| Gross Profit | -13.40% | 4.74% | -90.10% | -106.65% | -99.35% |
| SG&A Expenses | 11.75% | 2.17% | -2.65% | -6.30% | -15.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.89% | 3.66% | 5.56% | 3.44% | -4.38% |
| Operating Income | -3.38% | -6.50% | -9.19% | -28.41% | -17.59% |
| Income Before Tax | -62.74% | -32.86% | -66.31% | -88.18% | -23.53% |
| Income Tax Expenses | -308.33% | -291.48% | -1,627.12% | -1,169.14% | -132.26% |
| Earnings from Continuing Operations | -61.65% | -31.63% | -64.15% | -85.78% | -23.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -61.65% | -31.63% | -64.15% | -711.20% | -490.22% |
| EBIT | -3.38% | -6.50% | -9.19% | -28.41% | -17.59% |
| EBITDA | -7.23% | -9.63% | -16.75% | -39.52% | -32.26% |
| EPS Basic | -46.69% | -22.65% | -47.68% | -475.23% | -382.32% |
| Normalized Basic EPS | -29.58% | -2.87% | 0.21% | -9.93% | 8.46% |
| EPS Diluted | -46.69% | -22.65% | -47.68% | -475.23% | -382.32% |
| Normalized Diluted EPS | -29.58% | -2.87% | 0.21% | -9.93% | 8.46% |
| Average Basic Shares Outstanding | 12.13% | 9.78% | 10.73% | 13.64% | 19.61% |
| Average Diluted Shares Outstanding | 12.13% | 9.78% | 10.73% | 13.64% | 19.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |